$1.07 USD
General News
Meropi Kyriacou Honored as TNH Educator of the Year
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
LONDON — The European Medicines Agency has granted its first approval for a drug to treat the new coronavirus — remdesivir, which has been shown in trials to speed the recovery time of people hospitalized with COVID-19.
The regulatory agency says it was granting a conditional marketing authorization for remdesivir to be used in treating adults and adolescents older than 12 with pneumonia who require oxygen.
“Remdesivir is the first medicine against COVID-19 to be recommended for authorization in the EU,” the agency says. Last month, the U.S. Food and Drug Administration granted an emergency use authorization for the drug.
Although larger trials on remdesivir are still ongoing, preliminary results showed that patients hospitalized with severe illness were discharged quicker from the hospital than those who didn’t get the drug. No beneficial effect was seen in patients with mild or moderate disease.
